Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amgen Sees Strong Q4 Growth Even Without Horizon Contribution
Gains Driven By Volume For Many Products
Feb 07 2024
•
By
Mandy Jackson
Amgen's full-year 2024 revenue guidance is $32.4bn-$33.8bn • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip